Tarsus Pharmaceuticals

πŸ‘₯ 101-250πŸ’° $75,000,000 Post-IPO Debt 11 months agoBiotechnologyBiopharmaLife ScienceπŸ“ˆ Public Company
Website LinkedIn Email Twitter

Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies to address significant market opportunities, primarily in ophthalmic conditions. Our lead product candidate, TP-03, is a novel therapeutic currently in Phase 2b/3 clinical trials for the treatment of Demodex blepharitis, showcasing our commitment to addressing unmet medical needs. As a company of 101-250 employees, we leverage a robust tech stack including DNSSEC, Amazon Web Services (AWS) for cloud infrastructure, and BootstrapCDN for content delivery, ensuring a mobile-optimized experience for our users. We operate in a hybrid work environment and offer remote work options for many roles. Our culture thrives on commitment to patients, empowering innovation, and teamwork to amplify impact. We are a publicly traded company (NASDAQ:TARS), and our Series B funding round helped us to accelerate our research and development efforts. Our team is passionate about our mission to create category-creating products and is empowered to champion innovation. We have built a team of experts in ophthalmology and other therapeutic categories, with a focus on delivering on our promise to patients. Tarsus Pharmaceuticals is dedicated to attracting and retaining top talent by providing competitive compensation, including a comprehensive benefits package, stock equity and ensuring work-life balance through generous paid time off.

Related companies:

🏒 Wheel
πŸ‘₯ 101-250πŸ’° $150,000,000 Series C about 3 years agoπŸ«‚ Last layoff over 2 years agomHealthMedicalInformation TechnologyHealth Care
Website LinkedIn Email Facebook Twitter

Jobs at this company:

Apply

πŸ“ United States

🧭 Full-Time

πŸ’Έ 259500.0 - 363300.0 USD per year

πŸ” Pharmaceutical

  • PhD or MD/PhD degree in Biology, Pharmacology, Molecular or Cell biology or related life sciences field with 15+ years’ experience and a minimum of 10+ years in the pharmaceutical or industry setting.
  • In-depth understanding and recognized scientific leader with expertise in scientific drug development for assets progressing through pre-clinical and IND-enabling studies and/or Phase I/II trials.
  • Superior knowledge and solid understanding of emerging research, mechanisms of action and disease models in anterior and posterior segment eye care diseases, preclinically and clinically.
  • Knowledge of the clinical landscape in ophthalmology indications with good understanding of novel agents and impact to this landscape.
  • Excellent oral and written communication skills, including writing, reviewing, and editing scientific documents.
  • Superior interpersonal skills, diplomacy, and positive-influencing abilities.
  • Exceptional communication, influencing and partnering skills to drive decision-making within a multi-disciplinary, matrix teams.
  • Ability to demonstrate effective leadership behaviors to ensure effective outcomes, including business agility as well as a curious, open-minded, and solution focused mindset.
  • Effective project management skills.
  • Strong presentation skills; must be able to provide succinct, strategic, and actionable insights to senior executives.
  • Proactive self-starter who can lead work independently, with the ability to see the next step and anticipate issues.
  • Scientifically independent.
  • Enterprise and entrepreneurial mindset.
  • Subject Matter Expert in Pharmacology, Pathophysiology and drug target biology for both anterior and posterior segment diseases.
  • Establish and maintain strong external partnerships with key opinion leaders, academic institutions and other external partners and be seen as a scientific thought leader in the field of ophthalmology.
  • Partner with key internal experts across the company including Clinical Development, Innovation Lab and Business Development (BD) to drive translational strategy from preclinical development through candidate selection and contribute to translational strategies in early clinical development through early Proof of Concept.
  • Establish stage-appropriate project translational strategy for a differentiated asset to address unmet patient need with key β€œGo/No Go” decision points.
  • Design and execute non-clinical experiments to support MOA-related translational questions as well as overall understanding of the disease treatment approaches.
  • Build and develop deep internal expertise in disease areas within ophthalmology, which are prioritized by the company. Identify possible mechanisms, disease models, preclinical POC approaches.
  • Generate clear, testable translational hypothesis to address unmet needs (mechanism of action, pharmacodynamics, patient selection).
  • Identify most relevant models, liaise with the best CRO and interact with academic experts to evaluate potential assets.
  • In collaboration with clinical development, define translational strategy on projects with the objective to guide clinical development: indication identification, patient stratification strategy, combination potential, optimization of dose selection, overall biomarker strategy, etc.
  • In partnership with clinical development, build the differentiation strategy for the therapeutic as well as defining the clinical and mechanism of action hypothesis and disease indication selection for early clinical development.
  • Contribute to hypothesis-driven study design, execution, and data analysis, including identification of most relevant preclinical and ex vivo models.
  • Identify key scientific questions in the projects and builds translation sciences plan according to their priority level.
  • Partner with BD and bring scientific expertise to evaluate and triage external assets and opportunities, identify main risk and mitigation plan and build additional evidence to enable Go/No Go decisions.
  • Partner with Innovation Lab team to prioritize various hypothesis, identify possible assets, generate evidence to enable advancement into clinical development.
  • Build open relationships with peers and external partners to ensure best decision making.

LeadershipProject ManagementBusiness DevelopmentData AnalysisMachine LearningCommunication SkillsAnalytical SkillsCollaborationProblem SolvingStrategic thinking

Posted 4 months ago
Apply